MYRIAD GENETICS, INC. (MYGN) Operating income 2016–2025
MYRIAD GENETICS, INC. (MYGN) annual operating income history from SEC filings — each fiscal year as reported.
-$387.2MFY2025 · since FY2016: $44.0M → -$387.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$387.2M | -213.5% |
| FY2024 | -$123.5M | +52.0% |
| FY2023 | -$257.4M | -83.1% |
| FY2022 | -$140.6M | +26.2% |
| FY2021 | -$190.5M | +34.2% |
| FY2020 | -$289.7M | -25.0% |
| FY2019 | -$231.7M | -3148.7% |
| FY2018 | $7.6M | -93.8% |
| FY2017 | $121.9M | +177.0% |
| FY2016 | $44.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More MYGN financial trends
MYGN RevenueMYGN Net incomeMYGN Net marginMYGN Gross profitMYGN Gross marginMYGN Operating marginMYGN Operating cash flowMYGN Free cash flowMYGN Capital expendituresMYGN Return on equityMYGN Stock buybacksMYGN Dividends paidMYGN Total assetsMYGN Total liabilitiesMYGN Shareholders’ equityMYGN overview →